HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.

AbstractPURPOSE:
Breast cancer stem cells (BCSCs) contribute to the initiation, development, and recurrence of breast carcinomas. β1,4-Galactosyltransferase V (B4GalT5), which catalyzes the addition of galactose to GlcNAcβ1-4Man of N-glycans, is involved in embryogenesis. However, its role in the modulation of BCSCs remains unknown.
MATERIALS AND METHODS:
The relationship between B4GalT5 and breast cancer stemness was investigated by online clinical databases and immunohistochemistry analysis. Mammosphere formation, fluorescence-activated cell sorting (FACS), and in-vivo assays were used to evaluate B4GalT5 expression in BCSCs and its effect on BCSCs. B4GalT5 regulation of Wnt/β-catenin signaling was examined by immunofluorescence and Ricinus communis agglutinin I pull-down assays. Cell surface biotinylation and FACS assays were performed to assess the association of cell surface B4GalT5 and BCSCs.
RESULTS:
B4GalT5, but not other B4GalTs, was highly correlated with BCSC markers and poor prognosis. B4GalT5 significantly increased the stem cell marker aldehyde dehydrogenase 1A1 (ALDH1A1) and promoted the production of CD44+CD24-/low cells and the formation of mammospheres. Furthermore, B4GalT5 overexpression resulted in dramatic tumor growth in vivo. Mechanistically, B4GalT5 modified and protected Frizzled-1 from degradation via the lysosomal pathway, promoting Wnt/β-catenin signaling which was hyperactivated in BCSCs. B4GalT5, located on the surface of a small subset of breast carcinoma cells, was not responsible for the stemness of BCSCs.
CONCLUSION:
B4GalT5 modulates the stemness of breast cancer through glycosylation modification to stabilize Frizzled-1 and activate Wnt/β-catenin signaling independent of its cell surface location. Our studies highlight a previously unknown role of B4GalT5 in regulating the stemness of breast cancer and provide a potential drug target for anticancer drug development.
AuthorsWei Tang, Meng Li, Xin Qi, Jing Li
JournalCancer research and treatment (Cancer Res Treat) Vol. 52 Issue 4 Pg. 1084-1102 (Oct 2020) ISSN: 2005-9256 [Electronic] Korea (South)
PMID32599982 (Publication Type: Journal Article)
Chemical References
  • FZD1 protein, human
  • Frizzled Receptors
  • Aldehyde Dehydrogenase 1 Family
  • ALDH1A1 protein, human
  • Retinal Dehydrogenase
  • B4GALT5 protein, human
  • Galactosyltransferases
Topics
  • Aldehyde Dehydrogenase 1 Family (analysis, metabolism)
  • Animals
  • Breast (pathology)
  • Breast Neoplasms (pathology)
  • Carcinoma, Ductal, Breast (pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Datasets as Topic
  • Female
  • Frizzled Receptors (metabolism)
  • Galactosyltransferases (genetics, metabolism)
  • Gene Knockdown Techniques
  • Humans
  • Mice
  • Neoplastic Stem Cells (pathology)
  • Proteolysis
  • Retinal Dehydrogenase (analysis, metabolism)
  • Tissue Array Analysis
  • Wnt Signaling Pathway
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: